|
|
||||||||
1Department of Cardiology, Medizinische Universtätsklinik Würzburg, 97080 Würzburg, Germany; and 2Department of Cardiovascular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, United Kingdom
Submitted 5 November 2003 ; accepted in final form 19 April 2004
| ABSTRACT |
|---|
|
|
|---|
aequorin bioluminescence; transgenic mouse
ATP + creatine). The functional and physical coupling of certain members of the CK isoenzyme family to the sites of energy production and utilization has underscored the integrated properties of this important enzyme system in excitable tissue, particularly in muscle cells (26). MM-CK, for example, is present in membrane vesicles of the sarcoplasmic reticulum (SR) isolated from skeletal muscle (15), suggesting that an efficient and fast energy replenishing system is necessary for optimal functioning of SR Ca2+-ATPase. This view is further supported by studies in transgenic mice in which Mito-CK and cytosolic M-CK are ablated, showing not only altered contractile properties in skeletal and diaphragm muscle but also impaired Ca2+ release and reuptake dynamics in myotubes of skeletal muscle (19, 20, 27). Although a direct link between the missing CK system and alterations in cellular Ca2+ homeostasis was postulated, studies of myocardial Ca2+ metabolism in CK-deficient mice have not been reported so far. Because the CK system in cardiac muscle differs from that in skeletal muscle in several important aspects, it is difficult to predict how Ca2+ handling in heart muscle will be affected by the loss of CK. On one hand, in addition to the upregulation of existing alternative energy generation systems such as glycolysis or the adenylate cyclase system, additional adaptational changes might have occurred in cardiac muscle of CK knockout mice that would be integrated into an already complex metabolic network. In fact, major adaptations, including shortened intracellular diffusion distances, were recently reported in hearts with combined knockout of M-CK and Mito-CK (M/Mito-CK/) (7). On the other hand, it is likely that functional consequences of CK knockout will differ between resting conditions, where energy supply and demand is balanced, and conditions of severe energy supply-demand mismatch in the sense that compensatory changes might be sufficient to enable normal cardiac performance at baseline but fail to maintain myocardial performance during substantial metabolic stress as induced by ischemia-reperfusion.
The goal of the present study was therefore twofold: The first aim was to characterize Ca2+ homeostasis on a beat-to-beat basis under physiological conditions in isolated, perfused CK-deficient hearts. The aequorin bioluminescence technique was adapted to test the hypothesis that the near complete loss of the CK system leads to direct alterations in myocardial Ca2+ homeostasis. The second aim was to test whether a cardiac phenotype can be unmasked by ischemia-induced metabolic stress. Because ischemia leads to imbalance of myocardial energy homeostasis, we tested whether CK-deficient hearts show increased susceptibility to ischemia-reperfusion injury and whether this is accompanied by alterations in Ca2+ homeostasis.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Isolated, perfused heart preparation. Hearts of wild-type and M/Mito-CK/ mice were isolated and perfused in a Langendorff preparation as described previously (18). Retrograde perfusion via the aorta was carried out at a constant coronary perfusion pressure of 75 mmHg. Modified Krebs-Henseleit buffer containing (in mM) 118 NaCl, 5.3 KCl, 2.0 CaCl2, 1.2 MgSO4, 0.5 EDTA, and 25 NaHCO3, with 10 glucose and 0.5 pyruvate as substrates, was used as described previously (18). All hearts were electrically paced with platinum pacemaker wires at 7 Hz. Cardiac temperature was monitored with a temperature probe attached to the right ventricle. Special care was taken to ensure isothermal conditions (37.0 ± 0.5°C) during the ischemia protocol with a temperature-regulated organ bath.
Measurement of isovolumic contractile performance. A water-filled balloon custom made of polyvinyl chloride film was connected to a pressure transducer (Statham P23 Db, Gould Instruments) for continuous recording of left ventricular (LV) pressure and heart rate. The size of the balloon was carefully matched to the size of the LV, and the balloon was large enough that a negligible pressure (<1.0 mmHg) resulted when the balloon alone was inflated up to the maximum volume used. The balloon was inflated to set LV end-diastolic pressure (LVEDP) between 6 and 8 mmHg for all hearts, and the balloon volume was then held constant. These perfusion modalities yielded a stable isovolumic LV performance with changes in LV developed pressure (LVDP) of <5% over 60 min of control perfusion.
Contractile performance data were digitized online at a sampling rate of 1 kHz by a 12-bit analog-to-digital converter and analyzed offline. LVDP, LVEDP, time to peak pressure (TP), and maximum and minimum rates of contraction and relaxation were derived from the pressure tracing.
Aequorin loading. This is the first report on measurements of Ca2+ transients with aequorin in perfused mouse hearts at 37°C, and the protocol is therefore described in detail. After an initial perfusion period of 510 min at 30°C with a Ca2+ concentration ([Ca2+]) in the coronary perfusate of 1.0 mM, aequorin was macroinjected with a technique adapted from the rat whole heart preparation (22) and modified for the intact mouse heart. Specifically, 35 µl of an aequorin-containing solution (1 µg/ml) were injected with a glass micropipette into the interstitium of the inferoapical region of the LV. Care was taken to avoid excess injection, which could produce dissection or an isolated pocket of aequorin within the tissue. Thereafter, the heart was positioned in an organ bath with the aequorin-loaded area of the LV directly toward the cathode of a photomultiplier and submerged in Krebs-Henseleit solution. Five to ten minutes after aequorin loading, [Ca2+] in the coronary perfusate was elevated in a stepwise fashion up to 2.0 mM, the temperature was slowly increased to 37°C, and the hearts were finally paced at 7 Hz. Preliminary experiments with different aequorin loading procedures including different perfusate [Ca2+] values and temperatures showed that this approach yielded the highest success rate for stable Ca2+ transients at 37°C.
To reduce signal-to-noise ratios, 10100 light cycles were averaged. As described for the analysis of the mechanical parameters, the wave-averaged light signals were analyzed for peak systolic (Lsys) and end-diastolic light (Ldiast), time to peak light (TPL), time constant of exponential light signal decay (
L; with use of the variable asymptote method), and time to 50% decrease of light signal (T50L).
Because myocardial tissue of the isolated, perfused hearts was used for biochemical analysis at the end of the experimental protocol, the method of fractional luminescence for quantitative calibration of the Ca2+ signal including Triton X lysis could not be applied in the present study. Therefore, in addition to the characterization of the time course parameters of the Ca2+ light signal, relative changes of the amplitude of the Ca2+ light transients (
L) are reported with the preischemic amplitude of the Ca2+ light transients as a normalization reference. The amount of aequorin consumed throughout the experiment was taken into account as previously described (22).
Experimental protocol. The experimental protocol was started 510 min after steady-state levels of all mechanical parameters were reached. Fifteen minutes of baseline perfusion were followed by 20 min of no-flow ischemia. During ischemia, time to contracture (TTC) was defined as the time from the onset of ischemia to the time when pressure exceeded 10 mmHg, and VOMC refers to the value of maximal contracture during ischemia. After 20 min of ischemia, flow was recommenced and hearts were reperfused for 30 min. After 15 and 30 min of reperfusion, aequorin light and functional parameters were again measured.
Statistical analysis. All data are expressed as means ± SE. Comparisons among groups were made by repeated-measures ANOVA. When significant effects were observed, paired and unpaired Student's t-tests were used as appropriate. Statistical analyses were performed with the use of Statview (Brainpower, Calabasas, CA), and values of P < 0.05 were considered statistically significant.
| RESULTS |
|---|
|
|
|---|
|
|
|
L, and negative first derivative of light signal with time, as indexes of Ca2+ resequestration into the SR, were found to be similar for wild-type and M/Mito-CK/ hearts (Table 2). This indicates that myocardial Ca2+ handling in terms of Ca2+ release and reuptake in CK-deficient hearts is unaltered during baseline perfusion conditions.
|
|
|
3-fold), reaching its peak within the first minute of reperfusion. After 15 min of reperfusion, [Ca2+] fell below preischemic values, but no differences between the groups were detectable, suggesting that the observed difference in postischemic LV function was not caused by prolonged or increased availability of Ca2+ to activate the myofilaments. | DISCUSSION |
|---|
|
|
|---|
Whereas Crozatier et al. (2) recently demonstrated impaired contraction behavior of CK-deficient myocytes and in situ hearts in response to
-adrenergic challenge, the present results now demonstrate that hearts of CK-deficient mice show an increased susceptibility to ischemia-reperfusion injury. This corresponds to alterations in Ca2+ homeostasis, demonstrating a key function of an intact CK system for maintenance of Ca2+ homeostasis under metabolic stress conditions.
Ca2+ handling in CK-deficient hearts under baseline conditions. To our knowledge, this is the first study to report results of successful Ca2+ measurements in intact, beating hearts of CK-deficient mice. Using the aequorin light technique, we were able to show that under baseline conditions intracellular Ca2+ handling was similar in CK-deficient and wild-type hearts. It is important to point out that special care was taken to perform these measurements in an intact, beating heart setup at a physiological temperature and with, compared with other small rodent hearts, high stimulation frequencies. Hampton et al. (5) were the first to demonstrate that quantitative and qualitative Ca2+ changes can be successfully measured with the aequorin bioluminescence method in isolated mouse hearts. However, a complex aequorin loading protocol was necessary, and, more importantly, the experiments were performed at a reduced temperature of 30°C (5). This nonphysiological temperature precludes the comparison of those results with the results of many other experiments, e.g., using 31P NMR spectroscopy or O2 consumption, acquired under more physiological conditions. Given the fact that thermodynamic limitations might be ultimately responsible for the differences in Ca2+ release and uptake in CK-deficient hearts, it is essential to ensure physiological experimental conditions. Finally, not only the extent but also the reproducibility of any ischemia-reperfusion injury is critically dependent on the precise and reliable maintenance of a physiological temperature.
In support of our finding of unchanged baseline Ca2+ handling, Boehm et al. (1) demonstrated in saponin-skinned muscle fibers of CK-deficient mice that SR function in terms of Ca2+ uptake is unaltered as long as sufficient glycolytic intermediates are present. Interestingly, in a recent report Crozatier et al. (2) showed that caffeine-induced Ca2+ release kinetics are significantly altered in skinned fibers of CK-deficient hearts whereas the kinetics of the Ca2+ transients were completely normal in isolated cardiomyocytes, suggesting that the presence of functioning mitochondria is a prerequisite for normal Ca2+ homeostasis in CK-deficient hearts. Different results were obtained in fura 2-loaded myotubes of CK-mutant skeletal muscle: whereas basal intracellular Ca2+ levels under standard conditions were similar to those in wild-type skeletal muscle, Ca2+ response on depolarization and Ca2+ uptake were significantly impaired. Interestingly, SR Ca2+-ATPase expression in skeletal muscle of CK-deficient mice was not altered (19). Thus if SR Ca2+-ATPase plays a role in the altered Ca2+ dynamics, this most likely occurs through structural redistribution or a functional deficit rather than a decrease in overall content.
Thus the published data and the current results suggest that skeletal muscle, with its higher total CK activity and lower mitochondrial density and therefore lower capacity for aerobic ATP generation, is more dependent on an unaltered CK system to maintain normal Ca2+ homeostasis than heart muscle.
Increased susceptibility of CK-deficient hearts to ischemia-reperfusion. A central finding of the present study is that hearts lacking an efficient high-energy phosphate transport system are more susceptible to a challenge of severe energy supply-demand mismatch than wild-type hearts. It was shown previously that, although myocardial energetics are significantly altered in CK-deficient hearts, isovolumic contractile performance at moderate-workload conditions (comparable to the baseline perfusion conditions in the present study) was unaltered (17). This is in agreement with previous studies showing normal LV function at low workload in isolated rat hearts, even when CK activity was chemically inhibited to <1% of control (24). Only when extracellular [Ca2+] was increased to increase workload in these rat hearts was an impairment in contractile reserve observed. In contrast, increasing extracellular [Ca2+] in CK-ablated mouse hearts was not only well tolerated but also led to comparable increases in rate-pressure product or O2 consumption (17). As discussed by MacGowan et al. (13), it is reasonable to assume that Ca2+-induced inotropy is not an adequate challenge to maximally increase ATP utilization to achieve a situation of severe energy supply-demand mismatch. In contrast, prolonged myocardial ischemia imposes a metabolic stress that is a much more severe challenge for the heart than increasing force production by increasing extracellular [Ca2+]. Accordingly, 1020 min after the onset of ischemia, a gradual rise in diastolic tension, i.e., ischemic contracture, occurs. We demonstrated that in CK-deficient hearts the ischemic contracture occurred significantly earlier and was more pronounced. Despite extensive research (9, 21), the underlying mechanism(s) of the development of ischemic contracture in general is not completely understood. Two basic mechanisms have been proposed. First, the rise in tension can be caused by an increase in intracellular [Ca2+], leading to Ca2+-activated cross-bridge cycling, or second, cross bridges may lock in the rigor state as a result of a decrease in myocardial ATP and PCr levels or increased ADP levels (6, 23, 25). A number of recent experimental studies argue in favor of the second hypothesis. Eberli et al. (3) were able to show that when Ca2+ availability was experimentally altered during ischemia, there was no alteration in LV diastolic pressure, suggesting that ischemic diastolic dysfunction is not directly mediated by extra Ca2+-activated tension. Similarly, using NMR spectroscopy for direct measurement of high-energy phosphate and [Ca2+] during a prolonged period of ischemia, Koretsune and Marban (10) demonstrated that a fall in ATP coincides closely with the onset of contracture, whereas the profound intracellular acidosis and Pi accumulation during ischemia render the myofilaments insensitive to Ca2+.
What, therefore, is the relative contribution of these two mechanisms in causing ischemic contracture in the CK deficient hearts? We showed previously by NMR spectroscopy (17) as well as by HPLC analysis of CK-deficient hearts (16) that, despite the fact that the concentration of ATP in isolated well-perfused hearts was indistinguishable from that in wild-type hearts (9.6 ± 0.1 vs. 9.3 ± 0.2 mM), high- and low-energy phosphate levels at baseline (PCr 40%, ADP +170%, Pi +20%) were found to be significantly altered. Moreover, increasing cardiac workload leads to a significantly greater decrease in PCr (50%) and a greater accumulation of ADP (+95%), leading to larger decreases in free energy release from ATP hydrolysis (
GATP, 3.6 kJ/mol) compared with wild-type hearts (17). It is therefore reasonable to assume that during a period of more severe energy supply-demand mismatch as induced by ischemia energetic alterations are even more pronounced. Accordingly, it is hypothesized that the earlier and more pronounced occurrence of ischemic contracture in CK-deficient hearts is induced by an earlier fall in PCr and, more importantly, an earlier increase in myofibrillar ADP-to-ATP ratio, leading to a drop in
GATP. This in turn would facilitate the unrestrained entry of Ca2+ into the myocardial cells (resulting from a combination of increased Ca2+ influx, decreased Ca2+ efflux, and decreased Ca2+ reuptake by the SR), explaining the greater increase in diastolic [Ca2+] during the ischemic period. Because the minimal energy requirements of sarco(endo)plasmic reticulum Ca2+-ATPase are higher than those of myosin ATPase, alterations in Ca2+ homeostasis would be predicted to occur before the development of rigor cross bridges (8). However, more importantly, because the myofilaments during the ischemic period are rather insensitive to Ca2+ because of profound intracellular acidosis (9), the pattern and time course of the ischemic contracture are dissociated and/or independent from the changes in intracellular [Ca2+].
The significantly greater increase in intracellular [Ca2+] in CK-deficient hearts at the end of the ischemic period, however, has a significant impact on the subsequent reperfusion injury, known to be mediated by the transient Ca2+ overload within the first minutes of reperfusion (12). During the course of reperfusion, systolic and diastolic LV performance remained significantly impaired in both groups of hearts despite lower resting [Ca2+] during reperfusion. A possible mechanism is the decreased Ca2+ responsiveness of the postischemic myofilaments rather than the failure of activator Ca2+ delivery (4, 11).
However, direct experimental evidence, for example, by 31P NMR spectroscopy, demonstrating that thermodynamic limitations (
GATP) are responsible for the observed difference in the ischemic response in CK-deficient mouse hearts currently escapes detection because of the very limited temporal resolution of NMR spectroscopy in isolated mouse hearts (8 min in our hands), which exceeds the time difference in LVEDP increase between wild-type and CK-deficient hearts in the first minutes of ischemia.
In conclusion, the present study demonstrates that, during moderate workload, loss of an efficient CK system in transgenic CK-deficient hearts is well compensated by adaptational mechanisms. However, during more pronounced mismatches in energy supply and demand, such as induced by ischemia-reperfusion injury, significant alterations in LV performance and Ca2+ homeostasis become unmasked, providing further evidence for a key function of an intact CK system for maintenance of calcium homeostasis under metabolic stress conditions.
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
MHC403/+ mouse model of familial hypertrophic cardiomyopathy. J Clin Invest 101: 17751783, 1998.[ISI][Medline]
This article has been cited by other articles:
![]() |
M. Nahrendorf, J. U. Streif, K.-H. Hiller, K. Hu, P. Nordbeck, O. Ritter, D. Sosnovik, L. Bauer, S. Neubauer, P. M. Jakob, et al. Multimodal functional cardiac MRI in creatine kinase-deficient mice reveals subtle abnormalities in myocardial perfusion and mechanics Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2516 - H2521. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Saks, P. Dzeja, U. Schlattner, M. Vendelin, A. Terzic, and T. Wallimann Cardiac system bioenergetics: metabolic basis of the Frank-Starling law J. Physiol., March 1, 2006; 571(2): 253 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Momken, P. Lechene, N. Koulmann, D. Fortin, P. Mateo, B. T. Doan, J. Hoerter, X. Bigard, V. Veksler, and R. Ventura-Clapier Impaired voluntary running capacity of creatine kinase-deficient mice J. Physiol., June 15, 2005; 565(3): 951 - 964. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |